Prestige BioPharma Limited (950210.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 388.22B |
| Enterprise Value | 477.77B |
| P/E Ratio | -3.06 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 14.06 |
| Price/Book Ratio | 0.84 |
| Enterprise/Revenue | 17.5 |
| Enterprise/EBITDA | -7.51 |
Fiscal Year
| Fiscal Year | June 30, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -3.56 |
| Operating Margin | -3.59 |
AD
Management Effectiveness
| Return On Assets | -0.12 |
| Return On Equity | -0.22 |
Income Statement
| Revenue | 26.06B |
| Revenue/Share | 433.71 |
| Gross Profit | -30.81B |
| EBITDA | -60.84B |
| Net Income | -91.47B |
| Diluted EPS | -1,957.58 |
Balance Sheet
| Total Cash | 63.01B |
| Total Cash/Share | 1,048.42 |
| Total Debt | 106.11B |
| Total Debt/Equity | 0.24 |
| Current Ratio | 0.75 |
| Book Value Per Share | 8,435.64 |
Price History
| 52-Week Change | -53.15 |
| 52-Week High | 14,120 |
| 52-Week Low | 4,945 |
| Moving Average 50 Days | 6,205.4 |
| Moving Average 200 Days | 8,642.95 |
Statistics
| Average Volume | 46,276 |
| Shares Outstanding | 60.1M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
